全文获取类型
收费全文 | 2814篇 |
免费 | 151篇 |
国内免费 | 27篇 |
专业分类
耳鼻咽喉 | 17篇 |
儿科学 | 32篇 |
妇产科学 | 21篇 |
基础医学 | 449篇 |
口腔科学 | 37篇 |
临床医学 | 221篇 |
内科学 | 667篇 |
皮肤病学 | 29篇 |
神经病学 | 276篇 |
特种医学 | 201篇 |
外科学 | 379篇 |
综合类 | 13篇 |
一般理论 | 1篇 |
预防医学 | 152篇 |
眼科学 | 34篇 |
药学 | 246篇 |
中国医学 | 7篇 |
肿瘤学 | 210篇 |
出版年
2024年 | 6篇 |
2023年 | 35篇 |
2022年 | 83篇 |
2021年 | 148篇 |
2020年 | 93篇 |
2019年 | 90篇 |
2018年 | 100篇 |
2017年 | 75篇 |
2016年 | 62篇 |
2015年 | 102篇 |
2014年 | 105篇 |
2013年 | 136篇 |
2012年 | 256篇 |
2011年 | 225篇 |
2010年 | 122篇 |
2009年 | 112篇 |
2008年 | 144篇 |
2007年 | 181篇 |
2006年 | 165篇 |
2005年 | 131篇 |
2004年 | 129篇 |
2003年 | 99篇 |
2002年 | 88篇 |
2001年 | 47篇 |
2000年 | 39篇 |
1999年 | 33篇 |
1998年 | 8篇 |
1997年 | 12篇 |
1996年 | 7篇 |
1995年 | 6篇 |
1994年 | 10篇 |
1993年 | 4篇 |
1992年 | 16篇 |
1991年 | 7篇 |
1990年 | 6篇 |
1989年 | 5篇 |
1988年 | 6篇 |
1987年 | 10篇 |
1986年 | 6篇 |
1985年 | 8篇 |
1984年 | 5篇 |
1981年 | 5篇 |
1980年 | 4篇 |
1979年 | 7篇 |
1978年 | 8篇 |
1977年 | 8篇 |
1976年 | 6篇 |
1975年 | 4篇 |
1974年 | 4篇 |
1971年 | 3篇 |
排序方式: 共有2992条查询结果,搜索用时 109 毫秒
991.
F. Raeman W. De Cock T. De Beukelaar J. Leempoels J. De Cree H. Verhaegen 《Clinical rheumatology》1982,1(3):194-198
Summary The number of T-lymphocytes and T-lymphocyte subsets was measured in peripheral blood of 51 patients with rheumatoid arthiritis. T-lymphocytes were counted by E-rosette tests and by the immunogold staining method with OKT3.PAN monoclonal antibody. Helper and suppressor T-lymphocytes were determined by the immunogold staining method with OKT4.IND and OKT8.SUP monoclonal antibody. The relative and absolute numbers of T-lymphocytes and helper T-lympohocytes in peripheral blood of patients with RA did not differ significantly from those in the blood of healthy subjects. However, the relative and absolute numbers of suppressor T-cells were significantly lower in patients with RA than in healthy subjects. The decrease of suppressor T-cells in the blood of patients with RA dit not correlate with the activity of the disease nor the presence of the rheumatoid factor. 相似文献
992.
993.
Filip Weckx Manuela Tutolo Dirk De Ridder Frank Van der Aa 《Translational andrology and urology》2016,5(1):63-71
Neurogenic detrusor overactivity (NDO) can result in lower and upper urinary tract complications and eventually even in end-stage kidney failure. Since the driving force of this clinical cascade is high bladder pressure, controlling intravesical pressure in NDO patients improves both quality of life and life-expectancy in these patients. Botulinum toxin A (BTX-A) has proven its efficacy in reducing intravesical pressure and in reducing incontinence episodes. BTX-A also improves quality of life in patients with NDO. Both onabotulinumtoxinA (Botox®, Allergan, Irvine, USA) and abobotulinumtoxinA (Dysport®, Ipsen, Paris, France) have a level A recommendation for NDO-treatment. The recommended dose for intradetrusor injections in NDO patients is 200 U of onabotulinumtoxinA or 500 U of abobotulinumtoxinA. The drug is generally administered extratrigonal in the detrusor muscle, via cystoscopic guided injection at 20 sites in 1 mL injections. Intradetrusor BTX-A injections are safe, with mostly local complications such as urinary tract infection and high post-void residual or retention. The effect of the toxin lasts for approximately 9 months. Repeat injections can be performed without loss of efficacy. Different injection techniques, novel ways of BTX-A administration, eliminating the need for injection or new BTX-A types with better/longer response rates could change the field in the future. 相似文献
994.
Daniela Herzog Tereza Killianova Sigrid Pauwels Filip Germeys Yori Gidron 《Stress and health》2016,32(1):47-54
Past studies show that life events (LE) predict mental distress. This research tested whether hemispheric lateralization (HL) moderated the relationship between LE and mental distress. In studies 1 and 2, different instruments for assessing HL were used (questionnaire and neuropsychological test). In both studies, LE or daily hassles were positively correlated with distress (study 1) and with anxiety and depression (study 2), only in people with right but not left HL, controlling for effects of gender. In study 3, experimentally induced stress led to increased perceived stress, again only in participants with right but not left HL. These results show consistently that left HL may protect against adverse effects of LE, hassles or acute stress on well‐being. We propose possible mechanisms and future research directions. Copyright © 2014 John Wiley & Sons, Ltd. 相似文献
995.
Diabetic Ketoacidosis in a Patient with Type 2 Diabetes After Initiation of Sodium–Glucose Cotransporter 2 Inhibitor Treatment 下载免费PDF全文
Heidi Storgaard Jonatan I. Bagger Filip K. Knop Tina Vilsbøll Jørgen Rungby 《Basic & clinical pharmacology & toxicology》2016,118(2):168-170
Sodium–glucose cotransporter 2 inhibitors (SGLT2i) were recently introduced for the treatment of type 2 diabetes (T2D). SGLT2i lower plasma glucose by inhibiting the renal reuptake of glucose leading to glucosuria. Generally, these drugs are considered safe to use. However, recently, SGLT2i have been suggested to predispose to ketoacidosis. Here, we present a case of diabetic ketoacidosis (DKA) developed in an obese, poorly controlled male patient with T2D treated with the SGLT2i dapagliflozin. He was admitted with DKA 5 days after the initiation of treatment with the SGLT2i dapagliflozin. On admission, the primary symptoms were nausea and dizziness, and he was hypertensive (170/103) and tachycardic (119 bpm) and had mild hyperglycaemia (15.3 mmol/l), severe ketonuria and severe metabolic acidosis (pH 7.08). He responded well to infusions of insulin, glucose and saline and was discharged after 72 hr with insulin as the only glucose‐lowering therapy. After 1 month, dapagliflozin was reintroduced as add‐on to insulin with no recurrent signs of ketoacidosis. During acute illness or other conditions with increased insulin demands in diabetes, SGLT2i may predispose to the formation of ketone bodies and ensuing acidosis. 相似文献
996.
Flamaing J Knockaert D Meijers B Verhaegen J Peetermans WE 《Aging clinical and experimental research》2008,20(1):81-86
BACKGROUND AND AIMS: Community acquired lower respiratory tract infection (CALRTI) is the most common infection requiring hospitalization in the elderly. Sequential antibiotic therapy offers the potential for earlier functional rehabilitation, shorter length of hospital stay and lower costs. We studied the efficacy and safety of an empiric sequential antibiotic therapy with cefuroxime-cefuroxime axetil in elderly patients hospitalized with a CALRTI. METHODS: A prospective, randomized, open-label, in-hospital study of cefuroxime IV 750 mg tid for 10 days (IV group) vs cefuroxime 750 mg IV tid for 3 days, followed by cefuroxime-axetil PO 500 mg bid for 7 days (sequence group), when clinical (symptoms improved and fever disappeared) and/or laboratory response [decrease in C-reactive protein (CRP)] occurred. RESULTS: A total of 142 patients, 71 (mean age: 83.3 (+/-6 SD), M/F ratio: 1.1) in the IV group, and 71 (mean age: 81.5 (+/-7 SD), M/F ratio: 1.5) in the sequence group, were included in the study. Eighty-three (58.4%) presented with radiologically confirmed pneumonia (CAP) and 59 (41.6%) with non-pneumonic LRTI (NPLRTI) (p=ns between study groups). Treatment was considered effective in 84.5% (60/71) of patients in the IV group and 80.3% (57/71) in the sequence group (p=ns). Therapy failed in 15% (21/142) of the study population (p=ns between study groups) and, after day 3 of therapy, 8.45% (6/71) failed in both study groups. By the end of treatment, two patients had died in each study group, and total in-hospital mortality was 8.5% (12/142, p=ns between study groups). The length of hospital stay (LOS) did not differ between the two study groups. CONCLUSIONS: When a favorable clinical or biochemical response occurs on day 3 of IV cefuroxime therapy, further therapy with oral cefuroxime-axetil is as effective and safe as a full course of cefuroxime IV in elderly patients hospitalized with CALRTI. However, LOS was not reduced after sequential antibiotic therapy in this population. 相似文献
997.
Evaluation of 122 advanced‐stage cutaneous squamous cell carcinomas by comprehensive genomic profiling opens the door for new routes to targeted therapies 下载免费PDF全文
Rami N. Al‐Rohil MD Ashley J. Tarasen MD J. Andrew Carlson MD Kai Wang MD PhD Adrienne Johnson BS Roman Yelensky PhD Doron Lipson PhD Julia A. Elvin MD PhD Jo‐Anne Vergilio MD Siraj M. Ali MD PhD James Suh MD Vincent A. Miller MD Philip J. Stephens PhD Prasanth Ganesan MD Filip Janku MD PhD Daniel D. Karp MD Vivek Subbiah MD Martin C. Mihm MD Jeffrey S. Ross MD 《Cancer》2016,122(2):249-257
998.
999.
1000.